Prevalence of chronic kidney disease and its association with metabolic diseases: a cross-sectional survey in Zhejiang province, Eastern China
© Lin et al.; licensee BioMed Central Ltd. 2014
Received: 27 December 2013
Accepted: 29 January 2014
Published: 21 February 2014
The prevalence of chronic kidney disease (CKD) and metabolic diseases has increased at different rates in different regions in China. The aim of our study was to estimate the prevalence of CKD and to analyze associated risk factors of CKD in Zhejiang province, Eastern China.
A cross-sectional survey of 11,013 adults was conducted from September 2009 to June 2012 in Zhejiang Province, located in Eastern China. CKD was defined as having an estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m2 or the presence of albuminuria. Medical history, physical examination and laboratory data were used to diagnose metabolic diseases. Age- and sex-standardized prevalence was calculated using the data on the population distribution in China in 2010. We examined risk factors associated with decreased renal function and albuminuria using multivariate logistic regression.
A total of 10,384 adults (94.3%) completed the screening. The standardized prevalence of reduced renal function (eGFR < 60 mL/min/1.73 m2) was 1.83% (95% CI 1.52–2.13) and that of albuminuria was 8.65% (95% CI 7.98–9.31). The overall prevalence of CKD was 9.88% (95% CI 9.18–10.59). The prevalence of reduced renal function was greater in the eastern rural areas in Zhejiang province. Multivariate logistic regression revealed that metabolic diseases such as diabetes, obesity, hypertension, and hyperuricemia were independent risk factors of CKD. Patients with metabolic diseases had a significantly (P < 0.001) higher prevalence of CKD than those without such diseases.
CKD has become a severe public health problem in Zhejiang Province, and metabolic diseases may increase the risk of CKD in Zhejiang population.
KeywordsCross-sectional survey Chronic kidney disease Metabolic diseases Prevalence Risk factors Eastern China
The prevalence of chronic kidney disease (CKD) and metabolic diseases such as diabetes, obesity, hyperuricemia, hyperlipidemia and hypertension has increased and has become leading public health problem [1, 2]. China is a developing country with more than 30 provinces, autonomous regions and municipalities. Wang et al. reported that the prevalence of chronic kidney disease varied greatly between geographical regions . This might be related to variability in lifestyles and economic development. As a populous and economically developed province in eastern China, the permanent population of Zhejiang reached 54.42 million at the end of 2010. However, there are few reports about the prevalence of CKD in Zhejiang province.
Metabolic diseases such as diabetes, obesity and hypertension are known to be risk factors of kidney injury, and play an important role in the progression of CKD [4–6]. Hypertension and diabetes have been the leading causes of CKD in the developed countries. Approximately 40% of diabetic patients had some degree of CKD in the United States  and 40–50% of diabetic patients had kidney injury in Japan . Meanwhile, about 25.3% of patients with hypertension were reported to experience kidney injury in Turkey . Obesity conferred a high susceptibility to CKD in Norway with a relative risk of 1.77 .
Metabolic diseases have become major causes of CKD. Many epidemiological studies have found that geographic variation may lead to geographic risk factors for the occurrence of CKD. Geographic attributes may be as diverse as the physical and socioeconomic characteristics of a region and the available medical care . As a big province in a developing country, Zhejiang has its own geographic attributes, but an epidemiological survey studying the association between CKD and metabolic diseases had not been undertaken yet.
Therefore, the purpose of our study was to estimate the prevalence of CKD in Zhejiang province, with a focus on the CKD prevalence in individuals with metabolic diseases, and to analyze the associated CKD risk factors.
Study design and subjects
Screening protocol and evaluation criteria
All participants were required to complete a questionnaire including gender, age, family income, diet and medical history, physical examination (height, weight and blood pressure) and laboratory examination (fasting blood glucose, serum creatinine, serum lipids, serum uric acid, urinary albumin and urinary creatinine). All investigators received unified training before screening. Data testing and collection were completed at the local central hospital.
Chronic kidney disease
Chronic kidney disease was defined as having an estimated glomerular filtration rate (eGFR) of < 60 mL/min/1.73 m2 or the presence of albuminuria. Serum creatinine was measured by Jaffe’s kinetic method. The eGFR level was calculated by the simplified Modification of Diet in Renal Disease equation . Urinary albumin and urinary creatinine were measured using a spot morning urine sample. Urinary albumin was measured by the immunoturbidimetric method and urinary creatinine was measured by Jaffe’s kinetic method. The urinary albumin to creatinine ratio (ACR) was calculated. Albuminuria was defined as an ACR value higher than 30 mg/g. Micro-albuminuria was defined as an ACR ranging from 30 to 299 mg/g and macro-albuminuria with an ACR 300 mg/g or greater. CKD was classified based on the levels of eGFR and ACR according to KDIGO criteria .
Blood pressure measurement
Blood pressure was measured by sphygmomanometer at least 3 times with at least a 1 minute interval each time. The mean of these readings was calculated. If the difference between any two readings was greater than 10 mmHg, the mean of the closest two readings was used. Hypertension was defined as a systolic blood pressure (SBP) more than 140 mmHg, a diastolic blood pressure (DBP) more than 90 mmHg, any use of antihypertensive medication in the past 2 weeks irrespective of blood pressure, or a history of hypertension.
Fasting blood glucose and other measurements
Fasting blood glucose (FBS) was tested with a glucose oxidase method. The diagnosis of diabetes mellitus was established when the FBS was ≥ 7.0 mmol/L, or any use of oral hypoglycemic agents or insulin. Hyperlipidemia was defined as total cholesterol more than 5.18 mmol/L, triglycerides greater than 1.70 mmol/L or pharmacologic lipid-lowering therapy. Hyperuricemia was defined as a serum uric acid level greater than 417 mmol/L in males, or 357 mmol/L in females. Overweight was defined as a BMI of 25.00 to 29.99 kg/m2, and obesity was defined as a BMI more than 30.00 kg/m2.
Data input and analysis were done by more than two investigators together who had not participated in the screening. Continuous variables were presented as means ± SD, and categorical variables were expressed as proportions with 95% CIs. The standardization prevalence of CKD was adjusted for age and sex based on the population distribution in China in 2010. Differences in demographic and socioeconomic characteristics, and presence of metabolic conditions among participants with and without CKD, were analyzed using two-tailed unpaired student’s t-tests for continuous variables and chi-square tests for categorical variables. We examined risk factors associated with decreased renal function and albuminuria using multivariate logistic regression, and the results were expressed as odds ratios (ORs) with 95% CIs. Age (by decade), sex, hyperuricemia, diabetes, hypertension, obesity, hypertriglyceridemic and hypercholesterolemia as covariates were included in the multivariable logistic regressions. Statistical significance was set at a P value = 0.05. All analyses were done using the SPSS 19.0.
Demographic characteristics of the participants
Clinical features and metabolic characteristics of participants
58.3 ± 13.5
61.5 ± 14.7
66.5 ± 16.4
66.8 ± 15.1
70.4 ± 10.3
61.0 ± 14.7
51.6 ± 14.0
52.9 ± 14.5
146.9 ± 25.7
148.1 ± 25.3
145.2 ± 23.9
149.4 ± 25.8
161.6 ± 28.9
147.3 ± 25.4
131.2 ± 19.9
133.4 ± 21.4
84.2 ± 13.4
82.6 ± 12.4
79.5 ± 12.2
80.7 ± 14.2
83.4 ± 9.63
82.8 ± 13.0
78.2 ± 10.8
78.8 ± 11.2
5.69 ± 2.30
5.36 ± 1.76
5.07 ± 1.56
5.41 ± 1.08
4.92 ± 0.87
5.47 ± 2.00
5.03 ± 1.14
5.09 ± 1.30
1.70 ± 1.76
1.54 ± 1.09
1.52 ± 1.18
1.83 ± 2.13
1.33 ± 0.71
1.43 ± 1.60
1.45 ± 1.37
5.02 ± 1.08
4.89 ± 0.93
4.97 ± 1.18
4.91 ± 1.08
4.37 ± 0.08
4.96 ± 1.05
4.79 ± 1.42
4.81 ± 1.37
275.9 ± 80.4
316.2 ± 92.8
364.4 ± 105.0
435.9 ± 107.3
308.6 ± 98.1
288.0 ± 86.2
290.7 ± 88.2
23.8 ± 3.85
23.5 ± 4.23
23.2 ± 3.49
23.5 ± 4.22
21.9 ± 3.48
23.6 ± 3.93
23.0 ± 4.00
23.1 ± 3.99
123.7 ± 28.1
73.7 ± 7.91
54.8 ± 3.82
38.5 ± 4.21
16.1 ± 6.62
92.9 ± 37.3
105.8 ± 70.5
104.1 ± 32.7
149.7 ± 429.0
196.3 ± 329.6
91.8 ± 259.1
237.2 ± 448.4
354.1 ± 559.8
159.9 ± 380.7
10.0 ± 8.13
29.9 ± 147.8
Prevalence of CKD
Prevalence of chronic kidney disease (CKD) classified by eGFR and albuminuria categories (KDIGO 2012)
eGFR (mL/min Per 1.73 m²)
Prevalence (%, 95% CI)
Prevalence (%, 95% CI)
Prevalence (%, 95% CI)
Prevalence (%, 95% CI)
Prevalence of CKD in difference districts stratified by socio-economic disparities
Reduced renal function
Rural residents (A)
Urban residents (B)
Rural residents (C)
Urban residents (D)
Island residents (E)
Associated risk factors for CKD
Multivariate logistic regression analysis of factors associated with chronic kidney disease (CKD)
OR (95% CI)
OR (95% CI)
OR (95% CI)
OR (95% CI)
Age (change by 10 years)
Prevalence of CKD
To the best of our knowledge, this study was the first epidemiological survey of CKD in Zhejiang province. The overall prevalence of CKD in Zhejiang province (9.88%) was lower than results from a national survey (10.8%). Several cross-sectional studies indicated that the CKD prevalence differed substantially between geographical regions in China [17–19]. The prevalence of CKD in Beijing was 13.0%, which was much higher than the results we found for Zhejiang province. In the study from Zhuhai, Southern China, the overall prevalence of CKD was 12.5%. In Shanghai, the prevalence of CKD was 11.8%, which was also higher than our present study. Besides the differences in study methodology, this heterogeneity might be related to variability in socioeconomic characteristics. China is a developing country with 34 provinces, autonomous regions and municipalities. Significant differences in lifestyles, climatic conditions, medical care and economic development between geographical regions may cause the differences in the diseases’ prevalence. Xu et al.  reported that the prevalence of diabetes in Chinese adults increased with economic development. Wang et al. reported that the prevalence of CKD varied greatly between geographical regions.
In the analysis of different regions in Zhejiang, the eastern rural region had a rather high prevalence (4.83%) of reduced kidney function. In our study, eGFR was calculated using serum creatinine. To confirm these results, serum creatinine was measured again in the central laboratory of Zhejiang University First Hospital, and with the same results. The differences of socioeconomic status (lifestyles, medical insurance and family income) between the eastern and western regions of Zhejiang may have led to the variation in CKD , but these factors were not fully captured in our survey and deserve further investigation. Additionally, the high prevalence of hyperuricemia in this region may contribute to the high prevalence of reduced renal function. We found that the prevalence of hyperuricemia in the eastern rural region was greater than that in other regions. Hyperuricaemia was reported to increase the risk for new-onset kidney disease [21, 22]. The island residents had the highest prevalence of CKD in Zhejiang province. This may be because of the high sodium diet and unhealthy lifestyles, as a survey of lifestyles reported diet on the island of Zhejiang is typically high in sodium . High sodium intake is associated with increased micro-albuminuria and decreased renal function .
The risk factors of CKD
Our study suggests that metabolic diseases such as diabetes, obesity, hypertension, and hyperuricemia were independent risk factors of CKD. These results are consistent with previous studies [24, 25]. Zhejiang has undergone rapid social-economic development in the past decades. A rapid increase in metabolic diseases has taken place, which may be related to the changed lifestyles. Nationwide surveys of hypertension suggested that the prevalence of hypertension increased from 11.3 to 26.6% in the Chinese adult population ([26, 27], and the prevalence of diabetes increased from 5.5 to 9.7% [28, 29]. It suggests that diabetes has been the most common underlying cause for CKD . Obesity prevalence has doubled over the last 3 decades , and the rapid increase in the prevalence of metabolic diseases may result in an even greater burden of CKD. In our survey, patients with hypertension, diabetes, obesity and hyperuricemia had a higher prevalence of CKD than those without these diseases. For example, the prevalence of CKD in diabetics was 15.7%, which was only 7.07% in non-diabetics. Thus, slowing the rise in metabolic diseases may be a way of preventing CKD. Nevertheless, more studies are needed to confirm this hypothesis.
Our study has certain limitations and constraints. We did not measure HDL and LDL in our survey. High LDL cholesterol may be an independent risk factor of CKD. Our study also relied on single measurements for eGFR and albuminuria without repeated examination, because it was cumbersome and expensive, and that may have resulted in misclassification of individuals with CKD. Additionally, the cross-sectional design of the study makes causal inferences impossible.
CKD is an important public health problem in Zhejiang province, and metabolic diseases may increase the risk of CKD in Zhejiang population.
This study was supported by a grant from the Health Industry Special Scientific Research Projects, Ministry of Health (201002010).
- Levey AS, Atkins R, Coresh J, et al: Chronic kidney disease as a global public health problem: Approaches and initiatives - a position statement from kidney disease improving global outcomes. Kidney Int. 2007, 72: 247-259. 10.1038/sj.ki.5002343.View ArticlePubMedGoogle Scholar
- Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002, 287: 356-359. 10.1001/jama.287.3.356.View ArticlePubMedGoogle Scholar
- Zhang L, Wang F, Wang L, et al: Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012, 379: 815-822. 10.1016/S0140-6736(12)60033-6.View ArticlePubMedGoogle Scholar
- Chen J, Gu D, Chen CS, et al: Association between the metabolic syndrome and chronic kidney disease in Chinese adults. Nephrol Dial Transplant. 2007, 22: 1100-1106. 10.1093/ndt/gfl759.View ArticlePubMedGoogle Scholar
- Lea J, Cheek D, Thornley-Brown D, et al: Metabolic syndrome, proteinuria, and the risk of progressive CKD in hypertensive African Americans. Am J kidney Dis. 2008, 51: 732-740. 10.1053/j.ajkd.2008.01.013.View ArticlePubMedGoogle Scholar
- Nugent RA, Fathima SF, Feigl AB, Chyung D: The burden of chronic kidney disease on developing nations: a 21st century challenge in global health. Nephron Clin Pract. 2011, 118: c269-c277. 10.1159/000321382.View ArticlePubMedGoogle Scholar
- Laliberté F, Bookhart BK, Vekeman F, et al: Direct all-cause health care costs associated with chronic kidney disease in patients with diabetes and hypertension: a managed care perspective. J Manag Care Pharm. 2009, 15: 312-322.PubMedGoogle Scholar
- Ohta M, Babazono T, Uchigata Y, et al: Comparison of the prevalence of chronic kidney disease in Japanese patients with Type 1 and Type 2 diabetes. Diabet Med. 2010, 27: 1017-1023. 10.1111/j.1464-5491.2010.03049.x.View ArticlePubMedGoogle Scholar
- Altun B, Süleymanlar G, Utaş C, et al: Prevalence, awareness, treatment and control of hypertension in adults with chronic kidney disease in Turkey: results from the CREDIT study. Kidney Blood Press Res. 2012, 36: 36-46. 10.1159/000339025.View ArticlePubMedGoogle Scholar
- Hallan S, de Mutsert R, Carlsen S, et al: Obesity, smoking, and physical inactivity as risk factors for CKD: are men more vulnerable?. Am J Kidney Dis. 2006, 47: 396-405. 10.1053/j.ajkd.2005.11.027.View ArticlePubMedGoogle Scholar
- McClellan AC, Plantinga L, McClellan WM: Epidemiology, geography and chronic kidney disease. Curr Opin Nephrol Hypertens. 2012, 21: 323-328. 10.1097/MNH.0b013e3283521dae.View ArticlePubMedGoogle Scholar
- Lou D: Analysis on the difference of regional economic development of Zhejiang Province. Jing Ji Yan Jiu Dao Kan. 2009, 4: 102-103. [in chinese]Google Scholar
- Zhang YG, Liu H, Zhang Y, et al: Study on the economic growth and comprehensive strength of island in China. Zi Yuan Ke Xue. 2008, 30: 18-23. [in chinese]Google Scholar
- Chen Y, Guan JJ, Xia MZ: Survey of Zhoushan Islands Residents' Habits of Dietary. Zhongguo Shi Wu Yu Ying Yang. 2010, 12: 72-76. [in chinese]Google Scholar
- Ma YC, Zuo L, Chen JH, et al: Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006, 17: 2937-2944. 10.1681/ASN.2006040368.View ArticlePubMedGoogle Scholar
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group: KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Supplements. 2013, 3: 1-150.View ArticleGoogle Scholar
- Zhang L, Zhang P, Wang F, et al: Prevalence and factors associated with CKD: a population study from Beijing. Am J Kidney Dis. 2008, 51: 373-384. 10.1053/j.ajkd.2007.11.009.View ArticlePubMedGoogle Scholar
- Chen N, Wang W, Huang Y, et al: Community-based study on CKD subjects and the associated risk factors. Nephrol Dial Transplant. 2009, 24: 2117-2123. 10.1093/ndt/gfn767.View ArticlePubMedPubMed CentralGoogle Scholar
- Dong-feng GU, Yan-lin SHI, You-ming CHEN, et al: Prevalence of chronic kidney disease and prediabetes and associated risk factors: a community-based screening in Zhuhai, Southern China. Chin Med J. 2013, 126: 1213-1219.Google Scholar
- Xu Y, Wang L, He J, et al: Prevalence and control of diabetes in Chinese adults. JAMA. 2013, 310: 948-959. 10.1001/jama.2013.168118.View ArticlePubMedGoogle Scholar
- Boulware LE, Jaar BG, Tarver-Carr ME, et al: Screening for proteinuria in US adults: a cost-effectiveness analysis. JAMA. 2003, 290: 3101-3114. 10.1001/jama.290.23.3101.View ArticlePubMedGoogle Scholar
- Weiner DE, Tighiouart H, Elsayed EF, et al: Uric acid and incident kidney disease in the community. J Am Soc Nephrol. 2008, 19: 1204-1211. 10.1681/ASN.2007101075.View ArticlePubMedPubMed CentralGoogle Scholar
- Lin J, Fung TT, Hu FB, Curhan GC: Association of dietary patterns with albuminuria and kidney function decline in older white women: a subgroup analysis from the Nurses’ Health Study. Am J Kidney Dis. 2011, 57: 245-254. 10.1053/j.ajkd.2010.09.027.View ArticlePubMedPubMed CentralGoogle Scholar
- Ohno Y, Ishimura E, Naganuma T, et al: Prevalence of and factors associated with chronic kidney disease (CKD) in Japanese subjects without notable chronic diseases, undergoing an annual health checkup. Kidney Blood Press Res. 2012, 36: 139-148. 10.1159/000341490.View ArticlePubMedGoogle Scholar
- Najafi I, Shakeri R, Islami F, et al: Prevalence of chronic kidney disease and its associated risk factors: the first report from Iran using both microalbuminuria and urine sediment. Arch Iran Med. 2012, 15: 70-75.PubMedGoogle Scholar
- Wu X, Duan X, Gu D, Hao J, Tao S, et al: Prevalence of hypertension and its trends in Chinese populations. Int J Cardiol. 1995, 52: 39-44. 10.1016/0167-5273(95)02443-Z.View ArticlePubMedGoogle Scholar
- Gao Y, Chen G, Tian H, et al: Prevalence of hypertension in china: a cross-sectional study. PLoS One. 2013, 8: e65938-10.1371/journal.pone.0065938.View ArticlePubMedPubMed CentralGoogle Scholar
- Gu D, Reynolds K, Duan X, et al: Prevalence of diabetes and impaired fasting glucose in the Chinese adult population. Diabetologia. 2003, 46: 1190-1198. 10.1007/s00125-003-1167-8.View ArticlePubMedGoogle Scholar
- Yang W, Lu J, Weng J, et al: Prevalence of diabetes among men and women in China. N Engl J Med. 2010, 362: 1090-1101. 10.1056/NEJMoa0908292.View ArticlePubMedGoogle Scholar
- Levey AS, Coresh J: Chronic kidney disease. Lancet. 2012, 379: 165-180. 10.1016/S0140-6736(11)60178-5.View ArticlePubMedGoogle Scholar
- Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, et al: National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011, 377: 557-567. 10.1016/S0140-6736(10)62037-5.View ArticlePubMedPubMed CentralGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2369/15/36/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.